(Q44778953)

6 December 2017

Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors (English)

1 reference

6 December 2017

1 reference

Elizabeth J Reverri

1

1 reference

6 December 2017

Carolyn M Slupsky

series ordinal

2

1 reference

6 December 2017

Darya O Mishchuk

series ordinal

3

1 reference

6 December 2017

Francene M Steinberg

series ordinal

4

1 reference

6 December 2017

1 July 2016

1 reference

Molecular Nutrition and Food Research

6 December 2017

1 reference

6 December 2017

61

1 reference

6 December 2017

1

1 reference

A meta-analysis of the effect of soy protein supplementation on serum lipids

6 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women--a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Effect of soy isoflavones on circulating C-reactive protein in postmenopausal women: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Soy isoflavones and cardiovascular disease epidemiological, clinical and -omics perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Equol: history, chemistry, and formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

O-desmethylangolensin: the importance of equol's lesser known cousin to human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Is equol the key to the efficacy of soy foods?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Equol production changes over time in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Gut microbiota and cardiometabolic outcomes: influence of dietary patterns and their associated components

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

The gut microbiota, obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Biofluid 1H NMR-based metabonomic techniques in nutrition research - metabolic effects of dietary isoflavones in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Urinary (1)H-NMR metabonomics study on intervention effects of soya milk in Africans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Phytoestrogenic isoflavonoids in epidemiologic and clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Targeted profiling: quantitative analysis of 1H NMR metabolomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Early diet impacts infant rhesus gut microbiome, immunity, and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Molecular phenotyping of a UK population: defining the human serum metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Metabolite profiling identifies pathways associated with metabolic risk in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Metabolic signatures of insulin resistance in 7,098 young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Effect of whole soy and purified isoflavone daidzein on renal function--a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Soy food intake and circulating levels of inflammatory markers in Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Nutrimetabolomic strategies to develop new biomarkers of intake and health effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Application of biofluid 1 H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

Stability and Robustness of Human Metabolic Phenotypes in Response to Sequential Food Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201600132

21 January 2018

Identifiers

DOI

10.1002/MNFR.201600132

1 reference

6 December 2017

1 reference